Precision BioSciences, Inc. (DTIL) has a negative trailing P/E of -1.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -57.82%.
Criteria proven by this page:
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -1,061.4 | 0.00 | -1,844.03 | 1,248.37 | - |
| 2017 | -27.8 | -0.01 | -22.26 | 90.52 | - |
| 2018 | -18.6 | -0.37 | 21.40 | 78.57 | - |
| 2019 | -6.3 | -0.06 | 4.22 | 26.23 | - |
| 2020 | -4.0 | -0.71 | 9.77 | 17.87 | - |
| 2021 | -14.2 | 0.19 | 4.76 | 3.76 | - |
| 2022 | -0.9 | -0.01 | 1.73 | 4.17 | - |
| 2023 | -0.7 | 0.01 | 2.23 | 0.86 | - |
| 2024 | 3.6 | -0.03 | 0.46 | 0.38 | - |
| 2025 | -1.1 | 0.00 | 0.58 | 1.56 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.00 | $7.02M | $-8.25M | -117.6% |
| 2017 | $-18.81 | $6.48M | $-21.1M | -325.4% |
| 2018 | $-28.17 | $10.88M | $-46.04M | -423% |
| 2019 | $-59.50 | $22.24M | $-83.3M | -374.6% |
| 2020 | $-62.85 | $24.29M | $-109.01M | -448.9% |
| 2021 | $-15.80 | $115.53M | $-30.92M | -26.8% |
| 2022 | $-41.95 | $25.1M | $-122.91M | -489.7% |
| 2023 | $-15.96 | $48.73M | $-61.32M | -125.8% |
| 2024 | $1.04 | $68.7M | $7.17M | 10.4% |
| 2025 | $-3.63 | $34.26M | $-46.61M | -136% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.94 | $-2.94 – $-2.94 | $13.08M | $13.08M – $13.08M | 2 |
| 2027 | $-2.75 | $-2.75 – $-2.75 | $12.9M | $12.9M – $12.9M | 2 |
| 2028 | $-2.70 | $-3.30 – $-1.96 | $13.5M | $13.5M – $13.5M | 4 |
| 2029 | $-2.70 | $-2.70 – $-2.70 | $21.41M | $21.41M – $21.41M | 2 |
| 2030 | $-0.97 | $-0.97 – $-0.97 | $108.15M | $108.15M – $108.15M | 2 |
